The majority of individuals in both the pre- and post-SUFA cohorts were diagnosed at an advanced stage of HIV infection, with a median baseline CD4 count of 115 cells/mm3, 64.6% with CD4 counts ≤350, and 66.8% at clinical stage 3 or 4 post-SUFA. Here, CD4 is linked to HIV infectious disease.